Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-24-000020
Filing Date
2024-05-06
Accepted
2024-05-06 08:17:38
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20240331.htm   iXBRL 10-Q 1222816
2 EX-31.1 krys-20240331ex311.htm EX-31.1 10681
3 EX-31.2 krys-20240331ex312.htm EX-31.2 10644
4 EX-32.1 krys-20240331ex321.htm EX-32.1 11152
  Complete submission text file 0001711279-24-000020.txt   5664021

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20240331.xsd EX-101.SCH 35331
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20240331_cal.xml EX-101.CAL 62375
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20240331_def.xml EX-101.DEF 153089
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20240331_lab.xml EX-101.LAB 501618
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20240331_pre.xml EX-101.PRE 329589
66 EXTRACTED XBRL INSTANCE DOCUMENT krys-20240331_htm.xml XML 774867
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 24915731
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)